|
ZNF345 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14629972181035E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.55218110271016E-12 |
| Normal-vs-Stage2 |
3.555100E-03 |
| Normal-vs-Stage3 |
4.154300E-04 |
| Normal-vs-Stage4 |
6.907600E-02 |
| Stage1-vs-Stage2 |
2.544800E-01 |
| Stage1-vs-Stage3 |
1.036790E-01 |
| Stage1-vs-Stage4 |
3.835300E-03 |
| Stage2-vs-Stage3 |
9.227200E-01 |
| Stage2-vs-Stage4 |
2.285200E-01 |
| Stage3-vs-Stage4 |
2.112000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.80889999937762E-09 |
| Normal-vs-AfricanAmerican |
1.81360000000019E-05 |
| Normal-vs-Asian |
1.495840E-02 |
| Caucasian-vs-AfricanAmerican |
8.520300E-02 |
| Caucasian-vs-Asian |
3.058200E-02 |
| AfricanAmerican-vs-Asian |
1.638650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.287199999922E-07 |
| Normal-vs-Female |
3.4018998729124E-10 |
| Male-vs-Female |
1.169420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.093900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.8310025958549E-11 |
| Normal-vs-Age(61-80Yrs) |
1.6870499999988E-05 |
| Normal-vs-Age(81-100Yrs) |
9.795800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.610600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.064200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.140800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.078400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.750400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.999200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.408200E-04 |
| Normal-vs-Grade 2 |
8.04722954939052E-12 |
| Normal-vs-Grade 3 |
8.52300000020456E-07 |
| Normal-vs-Grade 4 |
9.047400E-01 |
| Grade 1-vs-Grade 2 |
1.755890E-02 |
| Grade 1-vs-Grade 3 |
6.161700E-04 |
| Grade 1-vs-Grade 4 |
3.95750000004025E-06 |
| Grade 2-vs-Grade 3 |
3.001900E-02 |
| Grade 2-vs-Grade 4 |
2.33559999995858E-06 |
| Grade 3-vs-Grade 4 |
7.792400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.64568358940187E-12 |
| Normal-vs-ccB subtype |
3.022500E-03 |
| ccA subtype-vs-ccB subtype |
1.577690E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09559999961206E-07 |
| Normal-vs-N1 |
6.313000E-01 |
| N0-vs-N1 |
3.909500E-02 |
|
|
